Current therapies in the management of systolic and diastolic dysfunction
- PMID: 22076576
- DOI: 10.1097/00003465-200111000-00001
Current therapies in the management of systolic and diastolic dysfunction
Abstract
Heart failure, especially caused by systolic dysfunction, is the most common cause of hospitalization in the elderly population and the annual expenditure required for its management is at least $10 billion. The critical care nurse can play an active role in recognizing the differences between systolic and diastolic dysfunction, and teaching the patient and family that improper management or underuse of therapies can lead to disease progression.
Similar articles
-
Office management of patients with diastolic heart failure.CMAJ. 2009 Mar 3;180(5):520-7. doi: 10.1503/cmaj.081048. CMAJ. 2009. PMID: 19255076 Free PMC article. Review. No abstract available.
-
The other side of heart failure.Johns Hopkins Med Lett Health After 50. 2009 Aug;21(6):4-5. Johns Hopkins Med Lett Health After 50. 2009. PMID: 19722311 No abstract available.
-
Chronic heart failure: current evidence, challenges to therapy, and future directions.Am J Cardiovasc Drugs. 2011 Jun 1;11(3):153-71. doi: 10.2165/11592090-000000000-00000. Am J Cardiovasc Drugs. 2011. PMID: 21619379 Review.
-
[Diastolic dysfunction in the elderly].Soins. 2011 Jun;(756 Suppl Cardiologie):S11-2. Soins. 2011. PMID: 21919295 French.
-
Pathophysiology of systolic and diastolic heart failure.Med Clin North Am. 2012 Sep;96(5):891-9. doi: 10.1016/j.mcna.2012.07.001. Med Clin North Am. 2012. PMID: 22980053 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources